Go offline with the Player FM app!
π Oral Semaglutide Enters the Arena β The SOUL Trial
Manage episode 476022759 series 2740117
The SOUL trial π§ͺ showed that oral semaglutide π significantly reduced major cardiovascular events β€οΈ (MACE) in people with type 2 diabetes π©Έ and ASCVD/CKD π.
Over ~4 years, it cut heart attacks π₯, lowered HbA1c π, reduced weight βοΈ, and inflammation π₯ β all with a once-daily pill ποΈ and no rise in serious side effects.
482 episodes
Manage episode 476022759 series 2740117
The SOUL trial π§ͺ showed that oral semaglutide π significantly reduced major cardiovascular events β€οΈ (MACE) in people with type 2 diabetes π©Έ and ASCVD/CKD π.
Over ~4 years, it cut heart attacks π₯, lowered HbA1c π, reduced weight βοΈ, and inflammation π₯ β all with a once-daily pill ποΈ and no rise in serious side effects.
482 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.